These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 14967239)

  • 1. Requirements for generating sigmoidal time-course aggregation in nucleation-dependent polymerization model.
    Kodaka M
    Biophys Chem; 2004 Feb; 107(3):243-53. PubMed ID: 14967239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interpretation of concentration-dependence in aggregation kinetics.
    Kodaka M
    Biophys Chem; 2004 May; 109(2):325-32. PubMed ID: 15110949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha-synuclein aggregation variable temperature and variable pH kinetic data: a re-analysis using the Finke-Watzky 2-step model of nucleation and autocatalytic growth.
    Morris AM; Finke RG
    Biophys Chem; 2009 Mar; 140(1-3):9-15. PubMed ID: 19101068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fitting neurological protein aggregation kinetic data via a 2-step, minimal/"Ockham's razor" model: the Finke-Watzky mechanism of nucleation followed by autocatalytic surface growth.
    Morris AM; Watzky MA; Agar JN; Finke RG
    Biochemistry; 2008 Feb; 47(8):2413-27. PubMed ID: 18247636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Energy barriers for HET-s prion forming domain amyloid formation.
    Sabaté R; Castillo V; Espargaró A; Saupe SJ; Ventura S
    FEBS J; 2009 Sep; 276(18):5053-64. PubMed ID: 19682303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fitting yeast and mammalian prion aggregation kinetic data with the Finke-Watzky two-step model of nucleation and autocatalytic growth.
    Watzky MA; Morris AM; Ross ED; Finke RG
    Biochemistry; 2008 Oct; 47(40):10790-800. PubMed ID: 18785757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetics of sickle hemoglobin polymerization. II. A double nucleation mechanism.
    Ferrone FA; Hofrichter J; Eaton WA
    J Mol Biol; 1985 Jun; 183(4):611-31. PubMed ID: 4020873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reconsidering the mechanism of polyglutamine peptide aggregation.
    Lee CC; Walters RH; Murphy RM
    Biochemistry; 2007 Nov; 46(44):12810-20. PubMed ID: 17929830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Model for the nucleation mechanism of protein folding.
    Djikaev YS; Ruckenstein E
    J Phys Chem B; 2007 Feb; 111(4):886-97. PubMed ID: 17249833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-native aggregation of alpha-chymotrypsinogen occurs through nucleation and growth with competing nucleus sizes and negative activation energies.
    Andrews JM; Roberts CJ
    Biochemistry; 2007 Jun; 46(25):7558-71. PubMed ID: 17530865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A single mutation in an SH3 domain increases amyloid aggregation by accelerating nucleation, but not by destabilizing thermodynamically the native state.
    Varela L; Morel B; Azuaga AI; Conejero-Lara F
    FEBS Lett; 2009 Feb; 583(4):801-6. PubMed ID: 19183554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of formation of amyloid protofibrils of barstar from soluble oligomers: evidence for multiple steps and lateral association coupled to conformational conversion.
    Kumar S; Mohanty SK; Udgaonkar JB
    J Mol Biol; 2007 Apr; 367(4):1186-204. PubMed ID: 17292913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thermodynamics and dynamics of amyloid peptide oligomerization are sequence dependent.
    Lu Y; Derreumaux P; Guo Z; Mousseau N; Wei G
    Proteins; 2009 Jun; 75(4):954-63. PubMed ID: 19089954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of heparin and dendrimers on the aggregation of two amyloid peptides related to Alzheimer's and prion diseases.
    Klajnert B; Cortijo-Arellano M; Bryszewska M; Cladera J
    Biochem Biophys Res Commun; 2006 Jan; 339(2):577-82. PubMed ID: 16310169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetics of nucleation-controlled polymerization. A perturbation treatment for use with a secondary pathway.
    Bishop MF; Ferrone FA
    Biophys J; 1984 Nov; 46(5):631-44. PubMed ID: 6498276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of inert volume-excluding macromolecules on protein fiber formation. II. Kinetic models for nucleated fiber growth.
    Hall D; Minton AP
    Biophys Chem; 2004 Feb; 107(3):299-316. PubMed ID: 14967245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Lumry-Eyring nucleated polymerization model of protein aggregation kinetics: 1. Aggregation with pre-equilibrated unfolding.
    Andrews JM; Roberts CJ
    J Phys Chem B; 2007 Jul; 111(27):7897-913. PubMed ID: 17571872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aggregation of a slow-folding mutant of a beta-clam protein proceeds through a monomeric nucleus.
    Ignatova Z; Gierasch LM
    Biochemistry; 2005 May; 44(19):7266-74. PubMed ID: 15882065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The double nucleation model for sickle cell haemoglobin polymerization: full integration and comparison with experimental data.
    Medkour T; Ferrone F; Galactéros F; Hannaert P
    Acta Biotheor; 2008 Jun; 56(1-2):103-22. PubMed ID: 18247134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of the mechanism of beta-amyloid fibril formation by kinetic and thermodynamic analyses.
    Lin MS; Chen LY; Tsai HT; Wang SS; Chang Y; Higuchi A; Chen WY
    Langmuir; 2008 Jun; 24(11):5802-8. PubMed ID: 18452319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.